Capital and Deals
Reed Jobs’s Yosemite Chases $350M Second Fund as AI Reshapes Cancer Drug Economics
Reed Jobs's oncology-only firm Yosemite is closing a $350M second fund, building a third of its companies from scratch as…
Capital and Deals
Reed Jobs's oncology-only firm Yosemite is closing a $350M second fund, building a third of its companies from scratch as…